RONALD MOORE: Open Payments
NPI 1578805123 · GEORGETOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,109 in 25 payments from 11 companies in 2025. Trend: 2023 $187 · 2024 $625 · 2025 $3,109
Debt forgiveness: $2,397Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 1 | $2,397 |
| ABBVIE INC. | 7 | $185 |
| Corium, LLC | 7 | $183 |
| Axsome Therapeutics, Inc. | 2 | $149 |
| Janssen Pharmaceuticals, Inc | 2 | $60 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $27 |
| Noven Therapeutics, LLC | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, VRAYLAR, Azstarys, Auvelity, SPRAVATO, REXULTI, Jornay PM, Xelstrym.
Industry payments across TX — which companies pay providers there.
